Indication
Intestinal
1 clinical trial
2 products
Clinical trial
An Adaptive Phase II/III SingleBlinded, Randomized, MultiCentre, ParallelGroup, Active Controlled, Superiority Study to Evaluate the Safety and Efficacy of a Single Day or 3day Single Dose of an ALBENDAZOLE IVERMECTIN Coformulation vs ALBENDAZOLE for the Treatment of SoilTransmitted Helminth Infections (Trichuris Trichiura, Hookworm, Strongyloides Stercoralis) in Paediatric and Young Adult PopulationStatus: Terminated, Estimated PCD: 2023-03-21
Product
Albendazole + IvermectinProduct
Albendazole